PI3K Akt signaling pathway activation and tumor resistance are closely related, and the application of this pathway inhibitor, such as PI3K inhibitor, Akt inhibitor, and mTOR inhibitor, can reverse the resistance of tumor cells and restore the sensitivity of tumor cells to chemotherapeutic drugs. This evidence concerns the gene AKT1 and neoplasm.